
One-line viva summary:
rtCGM with alerts is the standard.
Fix lows before highs.
Need 14 days and ≥70% wear.
TIR >70%, TBR <4% / <1% under 54, %CV ≤36%.
One or two changes only.
Arrows plus IOB — never stack insulin.
Part 1. What Is New in CGM (2025–2026)
1. Indication expanded beyond insulin dependence
Guidelines now support CGM from diabetes onset and anytime thereafter in:
Adults with diabetes on insulin (any regimen).
Adults on non-insulin drugs that trigger hypoglycemia (sulfonylureas, glinides).
Any patient in whom a real-time glucose profile will change titration or lifestyle advice.
2. Intermittently scanned CGM (isCGM) is no longer the standard
Current tech tables have dropped isCGM as the default. Real-time CGM (rtCGM) with automated high/low alerts and predictive alarms is the definitive standard of care.
3. No arbitrary barriers to pumps or AID
Initiation of CSII or automated insulin delivery must not require C-peptide cut-offs, islet autoantibody confirmation, or a mandatory period of prior MDI.
4. OTC / non-prescription sensors
Biosensors cleared for type 2 diabetes not on insulin and for prediabetes / wellness use have widened access. The clinician still needs a structured interpretation framework (AGP + DATUM steps below). An OTC trace is data — it is not automatically a complete diabetes plan.
5. Inpatient and critical-care use
CGM is validated for ward and step-down monitoring using hybrid protocols: believe the trend, confirm with capillary glucose when values are out of range or the trajectory is changing rapidly. ICU / vasopressor / shock states remain confirmation-heavy.
6. Interference is reduced, not abolished
Newer sensors have far less electrochemical interference from hydroxyurea, high-dose acetaminophen, ascorbic acid and maltose. High-dose IV vitamin C can still falsely elevate some enzymatic platforms. When the number and the patient disagree, check capillary glucose.
Part 2. Core Metrics and AGP Targets
A clinically actionable Ambulatory Glucose Profile needs a standardized 14-day collection with at least 70% active sensor wear. Less than that: do not make major regimen changes on a thin dataset.
Exam memory: TIR + TBR + %CV beat a lone A1c. Pregnancy uses a tighter range (63–140 mg/dL), not 70–180.
Part 3. DATUM — Systematic AGP Interpretation
Use this five-step sequence in clinic and in viva. Do not start with the pretty median curve.
DATUM mnemonic for viva: Data → Avoid lows → Turbulence (%CV) → Upward (TAR/median) → Minimal changes.
Part 4. Rate-of-Change Arrows and Correction
Arrows estimate interstitial velocity over the next 15–20 minutes. Always combine with insulin-on-board. Units below are teaching defaults — individualize by ISF.
Part 5. High-Yield Pitfalls
Physiological lag (5–15 min). Interstitial glucose trails capillary blood during exercise or a fast carbohydrate load. Symptoms ≠ sensor → fingerstick.
Compression lows. Sleeping on the sensor arm starves local perfusion. Overnight “severe hypo” that recovers as a vertical line when the patient turns is mechanical, not insulin. Check the raw overnight trace before cutting nocturnal basal.
Drug interference. Newer membranes block most paracetamol effect. High-dose IV ascorbic acid can still falsely raise some enzymatic sensors.
Lag-driven insulin stacking. Rising arrows tempt repeat corrections before the last subcutaneous dose has peaked. Delayed severe hypo 2–3 hours later. Teach IOB every visit.
Treating the A1c while ignoring TBR. A “good” A1c with TBR Level 2 >1% is a failed AGP.
Changing five settings at once. You will not know what worked. One or two actions, then 2–4 weeks.
Trusting <70% wear. Incomplete AGP is not a license for large titration.
OTC sensor without a plan. Wellness traces still need DATUM if they will change drugs.
Part 6. Quick Viva Cards
Sources
ADA Standards of Care in Diabetes (2026); ATTD consensus on CGM metrics and AGP; Endocrine Society diabetes technology statements; Braunwald 13th edition context for inpatient and cardiometabolic comorbidity. Class language is summarised for teaching — confirm exact COR/LOE in the parent document before quoting in a protocol.
meritmedscript.blogspot.com · Clinical exam notes · September 2026
Comments
Post a Comment
Join the academic discussion. Share your clinical insights, questions, or perspectives below.